VEGFA and urinary bladder carcinoma: Zhong et al. demonstrated that miR-29a inhibited VEGFA by directly targeting to its 3′UTR, thereby hindering the VEGFA/VEGFR2 pathway to exert tumor-suppressive effect in bladder carcinoma [69].